Geisinger clinical effectiveness program credited with stabilizing biologics costs
Biologics comprised less than 1% of Geisinger Health’s claims but were approaching 50% of its total drug spending. That is, until a comparative effectiveness program halted the rapid increase.
HFMA Offers Recommendations to Senate to Reduce Total Cost of Care while Improving Patient Outcomes
This letter contains HFMA's recommendations to the Senate HELP committee on ways to reduce the total cost of care while improving patient outcomes.
Healthcare Cost Containment: February 2019
Subscribers can access the February 2019 issue of Healthcare Cost Containment.
Annual Hospital Costs for Opioid Overdose Patients Approaches $2 Billion
The average cost for an overdose patient who was treated and released totaled $504, but the average cost rose to $11,731 for those that were treated and admitted to a hospital.
Evaluating Cost-of-Care Progress
Although more time and evidence are needed to prove the efficacy of population-based VBP models, there are other models that may be more appropriate for different populations.
Q&A: Executives Discuss Cost Accounting Obstacles, Opportunities
Feb. 15—Hospitals and health systems are increasingly pushing to better identify and reduce costs of care.
Health Care’s First Cost Accounting Adoption Model Is Now Available
Feb. 11—Amid an industrywide effort to better identify and reduce the cost of care, the HFMA-Strata L7 Cost Accounting Adoption Model, known as the L7 Model, was introduced this week.
Health Plan, Practices Focus on Care Overuse
Jan. 25—Although cost and quality are common features of value-based payment, a less common component is ensuring the provision of appropriate care.
Patient-Level Costing and Profitability: Making It Work
Healthcare providers can use patient-level costing to obtain accurate costing information.
Healthcare Cost Containment: December 2018
Subscribers can access the December 2018 issue of Healthcare Cost Containment.